-
2026.06.08 Gene Therapy Product “GT0003X” for Parkinson’s Disease Designated Under Japan’s “Regenerative Medical Products with SAKIGAKE Designation System”
-
2020.11.06 Notice regarding conclusion of contract with TAIYO HOLDINGS CO., LTD. and TAIYO PHARMA TECH CO., LTD. to manufacture gene therapy products
-
2020.06.24 Notice regarding Capital Alliance between Alfresa Corporation and Gene Therapy Research Institution Co., Ltd.
